Latest Apollo Projects
a collaboration with Dr Holger Auner and Prof Matthew Fuchter, Imperial College London
By Richard Butt
Dr Auner and Prof Fuchter have identified GCN2 as a key regulator of cellular metabolism and gene expression in multiple myeloma and initiated medicinal chemistry to identify novel GCN2 inhibitors. Based on this research Apollo and the Imperial team are now collaborating to run a structurally-enabled small molecule drug discovery project to deliver potent and selective GCN2 inhibitors into clinical studies.
< PREV ITEM | > NEXT ITEM a collaboration with Prof Edmund Kunji, University of Cambridge